INVO Fertility Announces 1:3 Reverse Stock Split Effective July 21, 2025.

INVO Fertility will effect a 1-for-3 reverse stock split effective July 21, 2025, at 12:01 a.m. Eastern Time. The company's common stock will trade on Nasdaq under the same symbol, "IVF," but with a new CUSIP number, 44984F708. Every 3 shares of issued and outstanding common stock will be exchanged for 1 share. The change aims to increase the company's stock price and improve its marketability.

INVO Fertility, Inc. (NASDAQ: IVF) has announced a 1-for-3 reverse stock split effective July 21, 2025, at 12:01 a.m. Eastern Time. The reverse stock split aims to increase the company's stock price and improve its marketability. As a result of the split, every 3 shares of issued and outstanding common stock will be exchanged for 1 share, with any fractional shares being rounded up to the next higher whole share.

Following the reverse stock split, the company's common stock will trade on Nasdaq under the same symbol, "IVF," but with a new CUSIP number, 44984F708. Immediately after the reverse stock split becomes effective, INVO Fertility will have approximately 928,272 shares of common stock issued and outstanding. Additionally, the company's authorized shares of common stock will be adjusted proportionately to 1,388,888 shares.

The reverse stock split is primarily intended to bring INVO Fertility into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing. However, no assurance can be given that such a reverse stock split will enable the company to regain compliance with the Nasdaq minimum bid price requirement.

INVO Fertility is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. The company's principal commercial strategy focuses on building, acquiring, and operating fertility clinics, including "INVO Centers" dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell® medical device. The IVC procedure provides patients with a more natural, intimate, and affordable experience compared to other ART treatments.

For more information, please visit www.invofertility.com.

References:
[1] https://finance.yahoo.com/news/invo-fertility-announces-1-3-120000298.html
[2] https://www.globenewswire.com/news-release/2025/07/17/3117139/0/en/INVO-Fertility-Announces-a-1-3-Reverse-Stock-Split-Effective-Pre-Market-Opening-on-July-21-2025.html